These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6683224)

  • 1. The role of 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT quinone methide) in the metabolism of butylated hydroxytoluene.
    Takahashi O; Hiraga K
    Food Chem Toxicol; 1983 Jun; 21(3):279-83. PubMed ID: 6683224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotope effects on the metabolism and pulmonary toxicity of butylated hydroxytoluene in mice by deuteration of the 4-methyl group.
    Mizutani T; Yamamoto K; Tajima K
    Toxicol Appl Pharmacol; 1983 Jun; 69(2):283-90. PubMed ID: 6868090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of butylated hydroxytoluene (BHT) to BHT-quinone methide in rats.
    Tajima K; Yamamoto K; Mizutani T
    Chem Pharm Bull (Tokyo); 1981 Dec; 29(12):3738-41. PubMed ID: 7340957
    [No Abstract]   [Full Text] [Related]  

  • 4. Generation of reactive intermediates from the tumor promoter butylated hydroxytoluene hydroperoxide in isolated murine keratinocytes or by hematin.
    Taffe BG; Zweier JL; Pannell LK; Kensler TW
    Carcinogenesis; 1989 Jul; 10(7):1261-8. PubMed ID: 2472232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT quinone methide): an active metabolite of BHT causing haemorrhages in rats.
    Takahashi O
    Arch Toxicol; 1988; 62(4):325-7. PubMed ID: 3240097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation and reactivity of alternative quinone methides from butylated hydroxytoluene: possible explanation for species-specific pneumotoxicity.
    Bolton JL; Sevestre H; Ibe BO; Thompson JA
    Chem Res Toxicol; 1990; 3(1):65-70. PubMed ID: 2131827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
    Thompson JA; Malkinson AM; Wand MD; Mastovich SL; Mead EW; Schullek KM; Laudenschlager WG
    Drug Metab Dispos; 1987; 15(6):833-40. PubMed ID: 2893710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peroxidative activation of butylated hydroxytoluene to BHT-quinone methide and stilbenequinone.
    Thompson DC; Cha YN; Trush MA
    Adv Exp Med Biol; 1986; 197():301-9. PubMed ID: 3766264
    [No Abstract]   [Full Text] [Related]  

  • 9. Decrease in blood coagulation factors II (prothrombin), VII, IX and X in the rat after a single oral dose of butylated hydroxytoluene.
    Takahashi O
    Food Chem Toxicol; 1987 Mar; 25(3):219-24. PubMed ID: 3570109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric retention and delayed absorption of a large dose of butylated hydroxytoluene in the rat.
    Takahashi O
    Xenobiotica; 1990 Dec; 20(12):1319-29. PubMed ID: 2075750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of quinone methide in the in vitro toxicity of the skin tumor promoter butylated hydroxytoluene hydroperoxide.
    Guyton KZ; Thompson JA; Kensler TW
    Chem Res Toxicol; 1993; 6(5):731-8. PubMed ID: 8292753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of covalent binding of butylated hydroxytoluene to microsomal protein.
    Nakagawa Y; Hiraga K; Suga T
    Biochem Pharmacol; 1983 Apr; 32(8):1417-21. PubMed ID: 6860361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA cleavage by metabolites of butylated hydroxytoluene.
    Nagai F; Ushiyama K; Kano I
    Arch Toxicol; 1993; 67(8):552-7. PubMed ID: 8285854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of butylated hydroxytoluene to toxic metabolites. Factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary microsomes.
    Bolton JL; Thompson JA
    Drug Metab Dispos; 1991; 19(2):467-72. PubMed ID: 1676656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further metabolism of 3,5-di-tert-butyl-4-hydroxybenzoic acid, a major metabolite of butylated hydroxytoluene, in rats.
    Yamamoto K; Tajima K; Takemura M; Mizutani T
    Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):512-4. PubMed ID: 2054880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of a glutathione conjugate from butylated hydroxytoluene by rat liver microsomes.
    Tajima K; Yamamoto K; Mizutani T
    Biochem Pharmacol; 1985 Jun; 34(12):2109-14. PubMed ID: 4004928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies using structural analogs and inbred strain differences to support a role for quinone methide metabolites of butylated hydroxytoluene (BHT) in mouse lung tumor promotion.
    Thompson JA; Carlson TJ; Sun Y; Dwyer-Nield LD; Malkinson AM
    Toxicology; 2001 Mar; 160(1-3):197-205. PubMed ID: 11246140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung toxicity and tumor promotion by hydroxylated derivatives of 2,6-di-tert-butyl-4-methylphenol (BHT) and 2-tert-butyl-4-methyl-6-iso-propylphenol: correlation with quinone methide reactivity.
    Kupfer R; Dwyer-Nield LD; Malkinson AM; Thompson JA
    Chem Res Toxicol; 2002 Aug; 15(8):1106-12. PubMed ID: 12184795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the metabolism of butylated hydroxytoluene (BHT) and lung tumor promotion in mice.
    Thompson JA; Bolton JL; Malkinson AM
    Exp Lung Res; 1991; 17(2):439-53. PubMed ID: 2050043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by butylated hydroxytoluene and its oxidative metabolites of DMBA-induced mammary tumorigenesis and of mammary DMBA-DNA adduct formation in vivo in the female rat.
    Singletary KW; Nelshoppen JM; Scardefield S; Wallig M
    Food Chem Toxicol; 1992 Jun; 30(6):455-65. PubMed ID: 1500032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.